RecruitingNot ApplicableNCT06457438
Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors
Sponsor
University Hospital Ostrava
Enrollment
300 participants
Start Date
Jan 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
In this study, the researchers want to focus on the prevalence of anti-HEV antibodies by a new generation test, direct detection of HEV RNA, and its genotypic analysis in a group of human tissue and cell donors.
Eligibility
Inclusion Criteria1
- \- patients indicated for organ or cell donation
Exclusion Criteria1
- \- none
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTElecsys Anti-HEV IgG, IgM
Diagnostic test used to determine antibodies in blood and serum.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06457438